[{"AccountsPayableCurrent_0_Q2_USD":1658000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_2_Q2_USD":27425000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-2644000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":-768000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":273000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":13037000.0,"DeferredTaxAssetsNetNoncurrent_0_Q2_USD":4788000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":2697000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":1304000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":2300000.0,"IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_2_Q2_USD":300000.0,"IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_1_Q2_USD":100000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":7442000.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q2_USD":-30000.0,"ForeignCurrencyTransactionGainLossBeforeTax_2_Q2_USD":-77000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q2_shares":244000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_2_Q2_shares":305000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":2269000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q2_USD":411000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":1304000.0,"AvailableForSaleSecuritiesAmortizedCost_0_Q2_USD":33356000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":2697000.0,"AvailableForSaleSecurities_0_Q2_USD":33190000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q2_USD":13.65,"ComprehensiveIncomeNetOfTax_2_Q2_USD":1704000.0,"DeferredRevenueCurrent_0_Q2_USD":4675000.0,"IncomeLossFromContinuingOperations_1_Q2_USD":1462000.0,"IncomeLossFromContinuingOperations_2_Q2_USD":1610000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":-942000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":94000.0,"DeferredIncomeTaxExpenseBenefit_2_Q2_USD":1388000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":3600000.0,"DepreciationDepletionAndAmortization_1_Q2_USD":1796000.0,"IncomeTaxesReceivable_0_Q2_USD":4257000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1_Q2_USD":900000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_2_Q2_USD":1100000.0,"AvailableForSaleSecuritiesCurrent_0_Q2_USD":33190000.0,"EarningsPerShareDiluted_1_Q2_USD":0.11,"EarningsPerShareDiluted_2_Q2_USD":0.12,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q2_USD":9500000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-174000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":-179000.0,"PaymentsToAcquireAvailableForSaleSecurities_2_Q2_USD":35863000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":14.24,"AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":166000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":15208000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-15153000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":539000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":243000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":1140000.0,"NumberOfOperatingSegments_2_Q2_Segment":2.0,"OperatingLeaseLiability_0_Q2_USD":3363000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":354000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":3009000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":2234000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.046,"OtherNoncashIncomeExpense_2_Q2_USD":-108000.0,"PayablesToCustomers_0_Q2_USD":490000.0,"PaymentForContingentConsiderationLiabilityFinancingActivities_2_Q2_USD":2592000.0,"PaymentForContingentConsiderationLiabilityOperatingActivities_2_Q2_USD":608000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":2373000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q2_USD":11935000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_2_Q2_USD":24077000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":22822000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":45438000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":597000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":537000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":548000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q2_USD":559000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":4503000.0,"ContractWithCustomerAssetNet_0_Q2_USD":6282000.0,"DeferredRevenueNoncurrent_0_Q2_USD":9861000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_Q2_USD":-14000.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"FairValueLiabilitiesLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"FairValueLiabilitiesLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_2_Q2_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_2_Q2_USD":0.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":520000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q2_USD":1177000.0,"GoodwillForeignCurrencyTranslationGainLoss_2_Q2_USD":105000.0,"ImpairmentOfInvestments_1_Q2_USD":479000.0,"ImpairmentOfInvestments_2_Q2_USD":479000.0,"IncreaseDecreaseInAccruedIncomeTaxesPayable_2_Q2_USD":-3615000.0,"IntangibleAssetsGrossExcludingGoodwill_0_Q2_USD":30101000.0,"InvestmentIncomeNet_1_Q2_USD":210000.0,"InvestmentIncomeNet_2_Q2_USD":460000.0,"LeaseCost_1_Q2_USD":100000.0,"LeaseCost_2_Q2_USD":300000.0,"GainLossOnSaleOfInvestments_2_Q2_USD":-479000.0,"UndistributedEarningsOfForeignSubsidiaries_0_Q2_USD":0.0,"ProvisionForDoubtfulAccounts_2_Q2_USD":137000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":4645000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-10749000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":1257000.0,"NetIncomeLoss_1_Q2_USD":1462000.0,"NetIncomeLoss_2_Q2_USD":1610000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":2311000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":3738000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":318000.0,"ProfitLoss_2_Q2_USD":1610000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":29785000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":112315000.0,"StockholdersEquity_0_Q2_USD":124966000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.05,"CommonStockSharesAuthorized_0_Q2_shares":45000000.0,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1_Q2_pure":0.21,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2_Q2_pure":0.21,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":17064000.0,"IncomeTaxesPaidNet_2_Q2_USD":6000.0,"InterestExpense_1_Q2_USD":30000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":-5647000.0,"InterestExpense_2_Q2_USD":70000.0,"LiabilitiesCurrent_0_Q2_USD":13278000.0,"Liabilities_0_Q2_USD":30581000.0,"AccountsReceivableNetCurrent_0_Q2_USD":8886000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":490000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":100000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":100000.0,"Assets_0_Q2_USD":155547000.0,"AssetsCurrent_0_Q2_USD":77301000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":15208000.0,"CommonStockSharesIssued_0_Q2_shares":13609495.0,"CommonStockSharesOutstanding_0_Q2_shares":13609495.0,"CommonStockValue_0_Q2_USD":680000.0,"CostsAndExpenses_1_Q2_USD":22978000.0,"CostsAndExpenses_2_Q2_USD":45860000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-485000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-587000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":-1947000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":-2197000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-128000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":622000.0,"InventoryNet_0_Q2_USD":5740000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":155547000.0,"OperatingIncomeLoss_1_Q2_USD":-156000.0,"OperatingIncomeLoss_2_Q2_USD":-422000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.05,"CostOfGoodsAndServicesSold_1_Q2_USD":3769000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":6972000.0,"EarningsPerShareBasic_1_Q2_USD":0.11,"EarningsPerShareBasic_2_Q2_USD":0.12,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0_Q2_USD":1591000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q2_USD":1596000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q2_USD":2247000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q2_USD":2287000.0,"Goodwill_0_Q2_USD":26276000.0,"IncomeTaxReconciliationOtherAdjustments_1_Q2_USD":1800000.0,"IncomeTaxReconciliationOtherAdjustments_2_Q2_USD":1800000.0,"NonoperatingIncomeExpense_1_Q2_USD":-329000.0,"NonoperatingIncomeExpense_2_Q2_USD":-165000.0,"OtherAssetsNoncurrent_0_Q2_USD":4360000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":218000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_2_Q2_USD":218000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":13507000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":13474000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":-1826000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":1000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":348000.0,"InventoryWorkInProcess_0_Q2_USD":1521000.0,"InventoryRawMaterials_0_Q2_USD":2997000.0,"PreferredStockSharesAuthorized_0_Q2_shares":450000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"PreferredStockValue_0_Q2_USD":null,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":6733000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":13676000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_Q2_pure":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1_Q2_pure":0.384,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2_Q2_pure":0.379,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":11481000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1_Q2_pure":0.014,"StockIssuedDuringPeriodValueStockOptionsExercised_2_Q2_USD":100000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":9000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":13751000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":13779000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q2_USD":240000.0,"AmortizationOfIntangibleAssets_1_Q2_USD":600000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":1300000.0,"IncreaseDecreaseInInventories_2_Q2_USD":1233000.0,"InventoryFinishedGoods_0_Q2_USD":1222000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2_Q2_pure":0.016,"UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_0_Q2_USD":2700000.0,"Ticker":"SRDX","CIK":"924717","name":"SURMODICS INC","OfficialName":"Surmodics Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"609353600.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20200430"}]